Huvitz Co., Ltd. (KOSDAQ:065510)
7,720.00
0.00 (0.00%)
At close: May 4, 2026
Huvitz Market Cap
Huvitz has a market cap or net worth of 80.97 billion as of May 6, 2026. Its market cap has increased by 8.50% in one year.
Market Cap
80.97B
Enterprise Value
150.84B
Revenue
118.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,720.00
Market Cap Chart
Since March 1, 2004, Huvitz's market cap has increased from 20.56B to 80.97B, an increase of 293.78%. That is a compound annual growth rate of 6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 80.97B | -16.48% |
| Dec 30, 2025 | 96.95B | 9.49% |
| Dec 30, 2024 | 88.55B | -57.18% |
| Dec 28, 2023 | 206.79B | 90.16% |
| Dec 29, 2022 | 108.74B | 14.73% |
| Dec 30, 2021 | 94.78B | 20.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TEMC CNS | 82.86B |
| Mr. Blue | 82.63B |
| SEKONIX | 82.21B |
| TRUEN | 81.86B |
| UBIVELOX | 81.47B |
| Incross | 81.23B |
| CENOTEC | 81.13B |
| Icure Pharmaceutical Incorporation | 81.09B |